Abstract
Purpose
Our aim was to develop a novel approach for lung cancer screening among a diverse population that integrates the Centers for Medicare and Medicaid Services (CMS) recommended components including shared decision making (SDM), low-dose CT (LDCT), reporting of results in a standardized format, smoking cessation, and arrangement of follow-up care.
Methods
Between October of 2015 and March of 2018, we enrolled patients, gathered data on demographics, delivery of SDM, reporting of LDCT results using Lung-RADS, discussion of results, and smoking cessation counseling. We measured adherence to follow-up care, cancer diagnosis, cancer treatment, and smoking cessation at 2 years after initial LDCT.
Results
We enrolled 505 patients who were 57% African American, 30% Caucasian, 13% Hispanic, < 1% Asian, and 61% were active smokers. All participants participated in SDM, 88.1% used a decision aid, and 96.1% proceeded with LDCT. Of 496 completing LDCT, all received a discussion about results and follow-up recommendations. Overall, 12.9% had Lung-RADS 3 or 4, and 3.2% were diagnosed with lung cancer resulting in a false-positive rate of 10.7%. All 48 patients with positive screens but no cancer diagnosis adhered to follow-up care at 1 year, but only 35.4% adhered to recommended follow-up care at 2 years. The annual follow-up for patients with negative lung cancer screening results (Lung-RADS 1 and 2) was only 23.7% after one year and 2.8% after 2 years. All active smokers received smoking cessation counseling, but only 11% quit smoking.
Conclusion
The findings show that an integrated lung cancer screening program can be safely implemented in a diverse population, but adherence to annual screening is poor.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics. CA Cancer J Clin 69(1):7–34
Aberle DR, Adams AM et al (2012) National Lung Screening Trial Research Team, Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5):395–409
Bach PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307(22):2418–2429
U.S. Preventive Services Task Force (2013) Lung cancer: screening. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening#Pod. Accessed 18 June 2020
Centers for Medicare and Medicaid Services (n.d.) Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Accessed 18 June 2020
Doria-Rose VP, White MC, Klabunde CN et al (2012) Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey. Cancer Epidemiol Biomark Prev 21(7):1049–1059
Japuntich SJ, Krieger NH, Salvas AL, Carey MP (2018) Racial disparities in lung cancer screening: an exploratory investigation. J Natl Med Assoc 110(5):424–427
Carter-Harris L, Slaven JE Jr, Monahan PO, Shedd-Steele R, Hanna N, Rawl SM (2018) Understanding lung cancer screening behavior: racial, gender, and geographic differences among Indiana long-term smokers. Prev Med Rep 10:49–54
Tangka FK, Subramanian S, Mobley LR et al (2017) Racial and ethnic disparities among state Medicaid programs for breast cancer screening. Prev Med 102:59–64
Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA (2015) Racial differences in outcomes within the national lung screening trial. Implications for widespread implementation. Am J Respir Crit Care Med 192(2):200–208
Wools A, Dapper EA, Leeuw JRJ (2015) Colorectal cancer screening participation: a systematic review. Eur J Public Health 26(1):158–168
EBSCO Health (n.d.) Shared decision making, patient decision aids, patient education, evidence-based patent information. https://health.ebsco.com/products/option-grid. Accessed 18 June 2020
Lau YK, Caverly TJ, Cao P et al (2015) Evaluation of a personalized, web-based decision aid for lung cancer screening. Am J Prev Med 49(6):e125-129
Kazerooni EA, Austin JHM, Black WC et al (2014) ACR–STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4)*. J Thorac Imaging 29(5):310–316
American College of Radiology (n.d.) Lung-RADS. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Lung-Rads. Accessed 18 June 2020
Shaik SS, Doshi D, Bandari SR, Madupu PR, Kulkarni S (2016) Tobacco use cessation and prevention - a review. J Clin Diagn Res 10(5):13–17
Ma J, Ward EM, Smith R, Jemal A (2013) Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer 119(7):1381–1385
Mazzone PJ, Tenenbaum A, Seeley M, Petersen H, Lyon C, Han X, Wang XF (2017) Impact of a lung cancer screening counseling and shared decision-making visit. Chest 151(3):572–578
Kinsinger LS, Anderson C, Kim J, Larson M et al (2017) Implementation of lung cancer screening in the Veterans Health Administration. JAMA Intern Med 177(3):399–406
Huo J, Hong YR, Bian J, Guo Y, Wilkie DJ, Mainous AG (2019) Low rates of patient-reported physician-patient discussion about lung cancer screening among current smokers: data from health information national trends survey. Cancer Epidemiol Biomark Prev 28(5):963–973
Moolgavkar SH, Holford TR, Levy DT, Kong CY et al (2012) Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975–2000. J Natl Cancer Inst 104(7):541–548
Villanti AC, Jiang Y, Abrams DB, Pyenson BS (2013) A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS ONE 8(8):e71379
Joseph AM, Rothman AJ, Almirall D et al (2018) Lung cancer screening and smoking cessation clinical trials. SCALE (smoking cessation within the context of lung cancer screening) collaboration. Am J Respir Crit Care Med 197(2):172–182
Pinsky PF, Gierada DS, Black W et al (2015) Performance of Lung-RADS in the national lung screening trial: a retrospective assessment. Ann Intern Med 162(7):485–491
Aberle DR (2017) Implementing lung cancer screening: the US experience. Clin Radiol 72(5):401–406
Muñoz-Largacha JA, Steiling KA, Kathuria H et al (2018) Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital. J Thorac Cardiovasc Surg 155(6):2674–2681
Erkmen CP, Mitchell M, Randhawa S et al (2018) An enhanced shared decision making model to address willingness and ability to undergo lung cancer screening and follow-up treatment in minority underserved populations. J Community Health 43(1):27–32
Alshora S, McKee BJ, Regis SM, Borondy Kitts AK, Bolus CC, McKee AB, French RJ, Flacke S, Wald C (2018) Adherence to radiology recommendations in a clinical CT lung screening program. J Am Coll Radiol 15(2):282–286
Robbins HA, Berg CD, Cheung LC, Chaturvedi AK, Katki HA (2019) Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result. J Natl Cancer Inst 111(9):996–999
Acknowledgments
This project was partially supported by TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership, Award Number U54 CA221704(5) from the National Cancer Institute of National Institutes of Health (NCI/NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCI/NIH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Erkmen, C.P., Dako, F., Moore, R. et al. Adherence to annual lung cancer screening with low-dose CT scan in a diverse population. Cancer Causes Control 32, 291–298 (2021). https://doi.org/10.1007/s10552-020-01383-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-020-01383-0